RJA
BHC icon

Raymond James & Associates’s Bausch Health BHC Stock Holding History

Raymond James & Associates’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$173K Sell
21,253
-6,399
-23% -$42.2K ﹤0.01% 3683
2024
Q2 		$193K Sell
27,652
-12,500
-31% -$94.6K ﹤0.01% 3614
2024
Q1 		$426K Buy
40,152
+637
+2% +$5.57K ﹤0.01% 3159
2023
Q4 		$317K Sell
39,515
-1,353
-3% -$9.86K ﹤0.01% 3247
2023
Q3 		$336K Buy
40,868
+322
+0.8% +$2.78K ﹤0.01% 3135
2023
Q2 		$324K Sell
40,546
-7,060
-15% -$52.1K ﹤0.01% 3207
2023
Q1 		$386K Sell
47,606
-475
-1% -$3.81K ﹤0.01% 3074
2022
Q4 		$302K Sell
48,081
-9,492
-16% -$66.3K ﹤0.01% 3210
2022
Q3 		$397K Sell
57,573
-73,529
-56% -$511K ﹤0.01% 2998
2022
Q2 		$1.1M Buy
131,102
+13,007
+11% +$182K ﹤0.01% 2372
2022
Q1 		$2.7M Sell
118,095
-94,665
-44% -$2.31M ﹤0.01% 1923
2021
Q4 		$5.87M Buy
212,760
+110,775
+109% +$2.97M ﹤0.01% 1448
2021
Q3 		$2.84M Sell
101,985
-9,650
-9% -$274K ﹤0.01% 1850
2021
Q2 		$3.28M Sell
111,635
-40,879
-27% -$1.24M ﹤0.01% 1780
2021
Q1 		$4.84M Buy
152,514
+7,968
+6% +$234K ﹤0.01% 1448
2020
Q4 		$3M Buy
144,546
+30,514
+27% +$569K ﹤0.01% 1637
2020
Q3 		$1.77M Sell
114,032
-22,689
-17% -$391K ﹤0.01% 1830
2020
Q2 		$2.5M Buy
136,721
+90,626
+197% +$1.6M ﹤0.01% 1590
2020
Q1 		$714K Sell
46,095
-81,689
-64% -$1.97M ﹤0.01% 2191
2019
Q4 		$3.82M Buy
127,784
+80,629
+171% +$2.1M ﹤0.01% 1421
2019
Q3 		$1.03M Sell
47,155
-68,430
-59% -$1.57M ﹤0.01% 2188
2019
Q2 		$2.91M Sell
115,585
-9,097
-7% -$216K ﹤0.01% 1564
2019
Q1 		$3.08M Buy
124,682
+22,842
+22% +$546K ﹤0.01% 1496
2018
Q4 		$1.88M Sell
101,840
-46,423
-31% -$1.1M ﹤0.01% 1697
2018
Q3 		$3.81M Sell
148,263
-1,982
-1% -$45.4K 0.01% 1395
2018
Q2 		$3.49M Buy
150,245
+60,944
+68% +$1.26M 0.01% 1398
2018
Q1 		$1.42M Buy
89,301
+13,860
+18% +$258K ﹤0.01% 1902
2017
Q4 		$1.57M Sell
75,441
-123,819
-62% -$1.96M ﹤0.01% 1846
2017
Q3 		$2.85M Sell
199,260
-11,917
-6% -$180K 0.01% 1399
2017
Q2 		$3.65M Sell
211,177
-203,185
-49% -$2.44M 0.01% 1196
2017
Q1 		$4.57M Buy
414,362
+115,726
+39% +$1.59M 0.01% 1062
2016
Q4 		$4.34M Buy
298,636
+119,479
+67% +$2.19M 0.01% 1063
2016
Q3 		$4.4M Buy
179,157
+29,289
+20% +$758K 0.01% 1016
2016
Q2 		$3.02M Buy
149,868
+45,500
+44% +$1.29M 0.01% 1112
2016
Q1 		$2.75M Buy
104,368
+78,436
+302% +$5.8M 0.01% 1113
2015
Q4 		$2.64M Buy
25,932
+5,954
+30% +$669K 0.01% 1117
2015
Q3 		$3.56M Sell
19,978
-6,790
-25% -$1.58M 0.01% 917
2015
Q2 		$5.95M Buy
26,768
+2,052
+8% +$455K 0.02% 734
2015
Q1 		$4.91M Buy
24,716
+5,094
+26% +$904K 0.02% 751
2014
Q4 		$2.81M Sell
19,622
-749
-4% -$101K 0.01% 978
2014
Q3 		$2.67M Buy
20,371
+3,715
+22% +$443K 0.02% 941
2014
Q2 		$2.1M Sell
16,656
-2,082
-11% -$266K 0.01% 1067
2014
Q1 		$2.47M Sell
18,738
-10,725
-36% -$1.47M 0.02% 912
2013
Q4 		$3.46M Buy
29,463
+11,353
+63% +$1.24M 0.03% 682
2013
Q3 		$1.89M Buy
+18,110
New +$1.76M 0.02% 914

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $3.66B AUM 25.21% 1-Year Est. Return

Raymond James & Associates's BHC Position: Q3 2024 in Review

Raymond James & Associates reduced its Bausch Health (BHC) stake by 23% in Q3 2024, selling an estimated $42.2K and leaving 21,253 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

Raymond James & Associates first reported a position in BHC in Q3 2013 and has held it in 45 quarters since. The position peaked at $5.95M in Q2 2015. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Raymond James & Associates held 21,253 shares of Bausch Health worth $173K as of Q3 2024.
  • Raymond James & Associates sold 6,399 Bausch Health shares in Q3 2024, an estimated $42.2K.
  • Bausch Health made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3683 holding.
  • Raymond James & Associates first reported a position in Bausch Health in Q3 2013 and has held it in 45 quarters since.
  • Raymond James & Associates's Bausch Health position peaked at $5.95M in Q2 2015.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.